Tel Aviv University
Tel Aviv, Israel
Purpose
to advance O-antigen-based Shigella vaccines through to licensure by providing the critical data on immunogenicity linked to efficacy required for immuno-bridging
Division
Global Health
Date
June 2018
Region Served
GLOBAL
Committed amount
$593,110
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
30
Grantee location
Tel Aviv, Israel
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.